BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2453860)

  • 1. Prolactin effect on the permeability of human benign hyperplastic prostate to testosterone.
    Farnsworth WE
    Prostate; 1988; 12(3):221-9. PubMed ID: 2453860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of prolactin and testosterone in the human prostate.
    Farnsworth WE; Slaunwhite WR; Sharma M; Oseko F; Brown JR; Gonder MJ; Cartagena R
    Urol Res; 1981; 9(2):79-88. PubMed ID: 6165128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of dihydrotestosterone, testosterone, estradiol, progesterone, or prolactin on the cell kinetics of human hyperplastic prostatic tissue in organ culture.
    de Launoit Y; Kiss R; Jossa V; Coibion M; Paridaens RJ; De Backer E; Danguy AJ; Pasteels JL
    Prostate; 1988; 13(2):143-53. PubMed ID: 2459683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
    Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin influences upon androgen action in male accessory sex organs.
    Thomas JA; Keenan EJ
    Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen dynamics in vitro in the normal and hyperplastic human prostate gland.
    Giorgi EP; Stewart JC; Grant JK; Scott R
    Biochem J; 1971 Jun; 123(1):41-55. PubMed ID: 4108500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; ZgliczyƄski S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
    Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
    Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    Bard DR; Lasnitzki I
    J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coregulatory effects of epidermal growth factor, dihydrotestosterone, and prolactin on benign human prostatic hyperplasia tissue culture proliferation.
    Janssen T; Petein M; van Velthoven R; De Decker R; Assenmacher C; Corbusier A; Pasteels JL; Kiss R; Schulman C
    Prostate; 1997 Jan; 30(1):47-52. PubMed ID: 9018335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia.
    Schweikert HU; Totzauer P; Rohr HP; Bartsch G
    J Urol; 1985 Aug; 134(2):403-7. PubMed ID: 2410636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of purified plasma proteins on testosterone uptake and metabolism by normal and hyperplastic human prostate in "constant-flow organ culture".
    Mercier-Bodard C; Marchut M; Perrot M; Picard MT; Baulieu EE; Robel P
    J Clin Endocrinol Metab; 1976 Aug; 43(2):374-86. PubMed ID: 59732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolactin on the metabolism of androgens by the rat ventral prostate gland in vitro.
    Manandhar MS; Thomas JA
    Invest Urol; 1976 Jul; 14(1):20-2. PubMed ID: 955845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
    Smith CM; Ballard SA; Wyllie MG; Masters JR
    J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen on the binding and metabolism of testosterone by human prostatic tissue and plasma in vitro.
    Habib FK; Rafati G; Robinson MR; Stitch SR
    J Endocrinol; 1979 Dec; 83(3):369-78. PubMed ID: 94084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered androgen metabolism in metastatic prostate cancer.
    Kliman B; Prout GR; Maclaughlin RA; Daly JJ; Griffin PP
    J Urol; 1978 May; 119(5):623-6. PubMed ID: 77915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
    Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
    Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.